Mark D Gretsinger, MD | |
3439 Granite Cir, Toledo, OH 43617-1161 | |
(419) 843-7996 | |
(419) 841-7725 |
Full Name | Mark D Gretsinger |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 3439 Granite Cir, Toledo, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407843758 | NPI | - | NPPES |
000000581578 | Other | ANTHEM | |
0753868 | Medicaid | OH | |
4095519 | Other | AETNA | |
P00659823 | Other | RAILROAD MEDICARE | |
00633 | Other | PARAMOUNT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 35051729G (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mark D Gretsinger, MD 3439 Granite Cir, Toledo, OH 43617-1161 Ph: (419) 843-7996 | Mark D Gretsinger, MD 3439 Granite Cir, Toledo, OH 43617-1161 Ph: (419) 843-7996 |
News Archive
Bruker Corporation today announced the release of the Vutara VXL Super-Resolution Fluorescence Microscope for nanoscale biological imaging. The new system opens an affordable and easy-to-use path for both core facilities and individual investigators to enter the world of super-resolution imaging by incorporating Bruker's industry-leading single-molecule localization (SML) technology in a streamlined system with compact footprint.
Northwestern University Feinberg School of Medicine researchers have identified a new and unusual role for a key player in the human immune system. A protein initially believed to regulate one routine function within the cell has proven vital for another critical step in the activation of the immune system.
Caraco Pharmaceutical Laboratories has announced that it will market Nimodipine Capsules, 30mg (Nimotop) on behalf of Sun Pharmaceutical Industries, Inc. (Sun), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd.
Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.
› Verified 9 days ago
Dr. Mani Khorsand Askari, M.D, FACP Gastroenterology Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave Ofc, Toledo, OH 43614 Phone: 419-383-6821 Fax: 419-383-6180 | |
Hoda Shabpiray, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3125 Transverse Dr, Toledo, OH 43614 Phone: 419-383-3627 Fax: 419-383-2021 | |
Theodore J. Ware, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2409 Cherry St, Suite 207, Toledo, OH 43608 Phone: 419-251-4696 Fax: 419-251-3572 | |
Muhammad Rizwan Faisal, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2142 N Cove Blvd, Toledo, OH 43606 Phone: 419-291-1111 | |
Drew Randall Oostra, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2109 Hughes Dr Ste 450, Toledo, OH 43606 Phone: 419-291-2003 Fax: 419-479-6977 | |
Dr. Caitlyn Marie Hollingshead, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave # Ms 1201, Toledo, OH 43614 Phone: 419-383-3780 Fax: 419-383-2021 | |
Naeem A Lughmani, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-479-5392 |